Lieping Chen
Papers
1
Total Citations
1
H-Index
1
About
Dr. Lieping Chen is a pioneering immunologist whose groundbreaking research has fundamentally reshaped our understanding of cancer immunotherapy. His key contributions center on the discovery and characterization of immune checkpoint pathways, most notably the PD-1/PD-L1 axis. Dr. Chen’s seminal work identified PD-L1 as a ligand for PD-1 and demonstrated its role in tumor immune evasion, laying the foundation for the development of checkpoint inhibitor therapies that have revolutionized oncology. His research has garnered over 100,000 citations, reflecting its profound impact on both basic immunology and clinical practice. Among his notable achievements, Dr. Chen was the first to clone the B7-H1 (PD-L1) molecule and elucidate its immunosuppressive functions, leading to the creation of drugs that have extended the lives of countless cancer patients. His recent work continues to explore novel immune regulatory mechanisms, including the role of the B7 family in T-cell activation. Dr. Chen’s legacy is defined by his relentless pursuit of translating immunological discoveries into life-saving treatments, making him a central figure in the field of immuno-oncology.
Research Focus
Key Achievements
Top Papers
- 1